KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Treasury Shares: 2019-2024

Historic Treasury Shares for Adaptive Biotechnologies (ADPT) over the last 6 years, with Dec 2024 value amounting to $10.2 million.

  • Adaptive Biotechnologies' Treasury Shares rose 9.43% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 9.43%. This contributed to the annual value of $10.2 million for FY2024, which is 5.23% up from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Treasury Shares is $10.2 million, which was up 5.23% from $9.7 million recorded in FY2023.
  • Over the past 5 years, Adaptive Biotechnologies' Treasury Shares peaked at $10.2 million during FY2024, and registered a low of $50,000 during FY2020.
  • For the 3-year period, Adaptive Biotechnologies' Treasury Shares averaged around $8.6 million, with its median value being $9.7 million (2023).
  • Data for Adaptive Biotechnologies' Treasury Shares shows a peak YoY spiked of 2,322.38% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Treasury Shares stood at $50,000 in 2020, then surged by 2,322.38% to $1.2 million in 2021, then soared by 393.87% to $6.0 million in 2022, then skyrocketed by 61.65% to $9.7 million in 2023, then climbed by 5.23% to $10.2 million in 2024.